Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
31,637,125
-
Total 13F shares
-
39,660,571
-
Share change
-
+156,991
-
Total reported value
-
$1,277,281,895
-
Put/Call ratio
-
44%
-
Price per share
-
$32.20
-
Number of holders
-
229
-
Value change
-
-$10,053,520
-
Number of buys
-
127
-
Number of sells
-
105
Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) as of Q2 2024
As of 30 Jun 2024,
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, $0.001 par value per share (COLL) was held by
229 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,660,571 shares.
The largest 10 holders included
BlackRock Inc., Pacer Advisors, Inc., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, Rubric Capital Management LP, Invesco Ltd., PRINCIPAL FINANCIAL GROUP INC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, and FULLER & THALER ASSET MANAGEMENT, INC..
This page lists
228
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.